跳至主要内容
临床试验/EUCTR2014-003148-11-NL
EUCTR2014-003148-11-NL进行中(未招募)不适用

Mechanism of action study of Ustekinumab treatment in psoriatic arthritis:Impact on cellular and molecular pathways of synovial inflammation and tissue remodeling - MoA-Ustekinumab

Academic Medical Center0 个研究点开始时间: 2015年1月26日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Psoriatic arthritis according to CASPAR criteria
  • - Active disease defined as: Swollen Joint count =3 and Tender Joint count =3
  • -Presence of knee and/or ankle arthritis in order to get synovial tissue biopsies
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 16
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Previous use of il-17 blocking therapy or multiple use of tnf-blocking therapies
  • -Contra-indication for needle arthroscopy such as joint replacement and anti-coagulation use.

研究者

发起方
Academic Medical Center

相似试验